Friday, September 25, 2009

Bernardi Warranty to Cease Operations on Nov 2

American Honda has notifed all dealers who are authorized to sell Honda Care and Acura Care service contracts that they can no longer sell them on-line as of November 2, 2009.

Honda Care and Acura Care are service contracts whose coverage goes above and beyond that of your car's standard factory warranty. The comprehensive exclusionary coverage of Acura Care and Honda Care cover virtually every component of your vehicle, including drivetrain, electronics, chassis, cooling/heating, and genuine factory accessories. The contract is unique in that it is transferable from private party to private party one time only.

As of November 1, 2009, BernardiWarranty.com will cease operations so as to comply with Honda's sales policy for its service contracts. Thus, you are encouraged to plan your Honda Care and Acura Care purchases so as to not miss the opportunity to purchase them on-line at a significant discount.

Please call 800.455.5905 with questions.

Tuesday, September 22, 2009

Honda Ranked Second Most Valuable Brand by Business Week


NEW YORK — Late last week, BusinessWeek and Interbrand, a brand consultancy, released their ninth annual Best Global Brands list, which ranked 100 companies by brand value and included 11 automakers.

Among the auto brands that made the list, Honda was ranked highest (No. 18th), down only 7 percent from last year. Toyota was ranked 8th, down 8% from last year.

Ford was the lone domestic brand to make the list at No. 49.

BusinessWeek’s Best Global Brands ranking is based on Interbrand’s formula that computes a value for brands by making sure each one derives at least a third of its earnings from outside of its home country, is recognized beyond its base of customers, and has publicly available marketing and financial data. Those criteria eliminate most telecoms, heavyweights that sometimes operate under different brand names internationally (such as Wal-Mart), airlines (too hard to separate from factors such as routes and schedules), pharmaceutical brands (consumers typically relate to the product rather than the brand), private companies, and portfolios of brands.